Grants4Targets-an innovative approach to translate ideas from basic research into novel drugs

被引:21
作者
Lessl, Monika [1 ]
Schoepe, Stefanie [1 ]
Sommer, Anette [1 ]
Schneider, Martin [1 ]
Asadullah, Khusru [1 ]
机构
[1] Global Drug Discovery Bayer Schering Pharma, D-13342 Berlin, Germany
关键词
D O I
10.1016/j.drudis.2010.11.013
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Collaborations between industry and academia are steadily gaining importance. To combine expertises Bayer Healthcare has set up a novel open innovation approach called Grants4Targets. Ideas on novel drug targets can easily be submitted to http://www.grants4targets.com. After a review process, grants are provided to perform focused experiments to further validate the proposed targets. In addition to financial support specific know-how on target validation and drug discovery is provided. Experienced scientists are nominated as project partners and, depending on the project, tools or specific models are provided. Around 280 applications have been received and 41 projects granted. According to our experience, this type of bridging fund combined with joint efforts provides a valuable tool to foster drug discovery collaborations.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 11 条
[1]
[Anonymous], SANOFI AVENTIS STREN
[2]
Chesbrough H., 2003, OPEN INNOVATION
[3]
Danner S., 2009, WHATS NEXT INNOVATIN
[4]
The target discovery process [J].
Egner, U ;
Krätzschmar, J ;
Kreft, B ;
Pohlenz, HD ;
Schneider, M .
CHEMBIOCHEM, 2005, 6 (03) :468-479
[5]
The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients [J].
Hunter, A. Jackie .
DRUG DISCOVERY TODAY, 2008, 13 (9-10) :371-373
[6]
Lessl M., 2010, WISSENSCHAFTSMANAGEM, V2, P34
[7]
Open innovation networks between academia and industry: an imperative for breakthrough therapies [J].
Melese, Teri ;
Lin, Salima M. ;
Chang, Julia L. ;
Cohen, Neal H. .
NATURE MEDICINE, 2009, 15 (05) :502-507
[8]
Drug discovery dilemma and Cura Quartet collaboration [J].
Shah, Salim ;
Federoff, Howard J. .
DRUG DISCOVERY TODAY, 2009, 14 (21-22) :1006-1010
[9]
Pharma embraces open source models [J].
Strauss, Stephen .
NATURE BIOTECHNOLOGY, 2010, 28 (07) :631-634
[10]
Open Innovation: share or die ... [J].
Talaga, Patrice .
DRUG DISCOVERY TODAY, 2009, 14 (21-22) :1003-1005